LAMPIRAN

Gambar 1. struktur proteoglikan

Gambar 2. Syndecan
 Gambar 3. Agreccan

Gambar 4. Matriks ekstrasel

Gambar 5. Proteoglikan membran dasar

Gambar 6. Struktur perlekan

 Gambar 7. Struktur agrin

Gambar 8. Struktur bamakan

Gambar 9. Proteoglikan jenis hyalektan

Gambar 10. Struktur versikan

Gambar 11. Struktur agrekan

 Gambar 12. Struktur neurokan

Gambar 13. Struktur brevikan

Gambar 14. Proteoglikan jenis SLRPs (Small Leucine-Rich Proteoglycans)

Gambar 15. Struktur SLRPs (Small Leucine-Rich Proteoglycans)

 Gambar 16. Struktur glukosamin

Gambar 17. Jalur pembentukkan heksosamin

Gambar 18. Jalur sintesis glukosamin dan turunannya

 Gambar 19. Stuktur kondroitin

Gambar 20. Pembentukkan prekursor gula nukleotida

 Gambar 21. Pembentukkan kondroitin

Gambar 22. Perbedaan tulang (A) dan tulang rawan (B)

Gambar 23. Komponen tulang rawan pada sendi

 Gambar 24. Penyakit osteoartritis

Gambar 25. Ikatan O-glikosidat antara GalNAc dan Ser

Gambar 26. Ikatan N-glukosamin antara GlcNAc dan nitrogen amida pada Asn
 Gambar 27. Jalur sintesis untuk pembentukan UDP-Gula dan PAPs

Gambar 28. Ringkasan struktur glikosaminoglikan dan pelekatanya pada protein inti
 Gambar 29. Sifat Utama Glikosaminoglikan

Gambar 30. Struktur Asam Hialuronat

Gambar 31. Asam Hialuronat ditulang dan tulang rawan (Kartilago)

Gambar 32. Asam Hialuronat di dalam mata

Gambar33. Asam Hialuronat di dalam kulit

Gambar 34. Biosynthesis Hyaluronat

Gambar 35. Skema degradasi HA

Gambar 36. Perbedaan biosintesis heparin sulfat, kondroitin sulfat atau glikosaminoglikan dermatan
sulfat.
Gambar 37. Biosintesis Heparin/Heparan sulfat
Gambar 38. Degradasi heparin/heparan sulfat

Gambar 39. Perbedaan disakarida dermatan sulfat

 Gambar 40. Degradasi dermatan sulfat

Gambar 41. Gambaran fungsi IdoA pada DS/CS. (A) peran IdoA pada penyimpanan sitokin growth
factor, (B) Borreliainfection, (C) atherosclerosis, (D) koagulasi, (E) P-selectin-dependent
leukocyte recruitment, (F) pengaktifan sitokin dan reseptor growth factor, dan (G)
pengarahan leukosit oleh ICAM.
Gambar 42. Struktur Keratan Sulfat

Gambar 43. Keratan Sulfat I

Gambar 44. Keratan Sulfat II

 DAFTAR PUSTAKA

Amado,M.,et al 1999. Identification and Characterization of Large Galactosyltransferase

Gene Families : Galactosyltransferases For All Function. Biochims. Biophys. Acta,
1473, 35-53 BiolChem 107: 629-634.

Barry FP et al. 1995. N- and O-linked keratan sulfate on the hyaluronan binding region of
aggrecan from mature and immature bovine cartilage. J Biol Chem 270: 20516-20524.

Carlsson P. and Kjellen L. 2012. Heparin Biosynthesis. Handbook of Experimental

Pharmacology 207, DOI 10.1007/978-3-642-23056-1_2, Springer-Verlag Berlin
Heidelberg

Ferdous Z, Grande-Allen K. 2007. Utility and control of proteoglycans in tissue engineering.

Tissue Engineering 138: 1893-1904.

Fraser JRE, Laurent TC, Laurent UBG. 1997 .Hyaluronan: Its nature,distribution, functions
and turnover. J Int Med 242: 27-33.

Harris ED et al. 2005. Structure and Function of Bone, Joints, and Connective Tissue.
Kelley's Textbook of Rheumatology. 7th ed.

Iozzo RV. 1998. Matrix proteoglycans: from molecular design to cellular function. Annual
Review of Biochemistry 671: 609-652.

Jiang, Dianhua, Jiurong Liang , Paul W. Noble. 2010. Hyaluronan as an Immune Regulator
in Human Diseases. Physiological Reviews Published 1 January 2011Vol. 91no. 221-
264DOI: 10.1152/physrev.00052.2009.

Jia, J. 2009. Structure and function of heparan sulfat/heparin-importance of glucoronyl C%-

epimerase and heparanase. Dissertation. Universitatis Upsaliensis Uppsala. Sweden.

Kappler J, Kaminski TP, Gieselmann V, Kubitscheck U, Jerosch J . 2010.Single-molecule

imaging of hyaluronan in human synovial fluid. J Biomed Opt. 15: 060504.

Kelly SG. 1998. The Role of Glucosamine Sulfate and Chondroitin Sulfates in the Treatment
of Degenerative Joint Disease. Alt Med Rev 3: 27-39.

Koolman,J dan Roehm, K.H,. 2005. Color Atlas of Biochemistry. New york : Thieme
Stuttgart.

Krusius,et al.1986. Identification of an O-glycosidic mannose-linked sialylated

tetrasaccharide and Keratan sulphate oligosaccharides in the chondroitin sulphate
proteoglycan of brain. J.Biol.Chem.,261, 8237-8242.

Kuc IM, Scott PG. 1997. Increased diameters of collagen fibrils precipitated in vitro in the
presence of decorin from various connective tissues. Conn Tissue Res 41:287-296.

Lauder RM et al. 1997. The structure of the keratan sulfate chains attached to fibromodulins
from human. Glycoconj J 14: 651-660.
Lippiello L. 2003. Glucosamine and chondroitin sulfate: biological response modifiers of
chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage 11:
335-342.

Lyle S et al. 1994. Rat chondrosarcoma ATP sulfurylase and adenosine 50-phosphosulfate
kinase reside on a single bifunctional protein. Biochemistry 33: 59205925.
Meena. Farid,et al. 2011. Hyaluronic Acid and Derivatives for Tissue Engineering. J
Biotechnol Biomaterial S3:001.

Meyer K, Palmer JW .1934. The polysaccharide of the vitreous humor. J

Morgelin M et al. 1998. Cartilage proteoglycans: Assembly with hyaluronate and link protein
as studied by electron microscopy. Biochem J 253: 175-185.

Murray,RK et al. 2009. Harpers Illustrated Biochemistry 27th Edition. New York : Medical
Publishing Division.

Nelson, David and Michael M. 2008. Lehninger Principles of Biochemistry 5th edition. New
York: W.H.Freeman And Company.

Onaya J. et al. 1999. Dermatan Sulfate as a Bifunctional Antithrombotic. Cardiovascular

Drug Reviews Vol. 17, No. 3, pp. 225236.

Polykratis et al. 2004. Identification of heparin affin regulatory peptide domain with potential
role on angiogenesis. The international Journal of biochemistry and cell biology 36:
1954-1966.

Prhem, Peter. 2008. Research on Hyaluronan. Institut fr Physiologische chemie Und

pathobiochemie.

Saliba M.J. 2001 Heparin In The Treatment Of Burns: Review Jurnal International Society
For Burn Injury. 27:349-358.

Sandy JD et al. 1990. Isolation and characterization of disulfide-bonded peptides from the
three globular domains of aggregating cartilage proteoglycan. J Biol Chem 265: 21108-
21113.

Sasisekharan R. et al. 2002. Roles Of Heparan-Sulphate Glycosaminoglycans In Cancer.

Nature Reviews Cancer. 521-528. DOI: 10.1038/nrc842.

Setnikar I et al. 1993. Pharmacokinetics of glucosamine in man. Arzneim Forsch 43: 1109-
1113.

Silbert JE, Sugumaran G. 2002. Biosynthesis of Chondroitin/Dermatan Sulfate. Life 54: 177
186.

Stern, Robert. 2004. Mammalian Hyaluronidases.Glycoforum science

Sugumaran G, Vertel BM. 2000. Biosynthesis of chondroitin sulfate and dermatan sulfate
proteoglycans. In Oligosaccharides in Chemistry and Biology: A Comprehensive
Handbook (Ernst, B., Hart, G., and Sinay, P., eds.). pp. 375394, Wiley VCH.

Svensson L et al. 1995. Decorin binding sites for collagen type I are mainly located in leucine
rich repeats 4-5. J Biol Chem 270: 20712-20716.

Tammi RH, Kultti A, Kosma VM, Pirinen R, Auvinen P, et al. 2008. Hyaluronan in human
tumors: pathobiological and prognostic messages from cell-associated and stromal
hyaluronan. Semin Cancer Biol 18: 288-295.

Teplyakov A et al. 2001. Channeling of ammonia in glucosamine-6-phosphate synthase. J

Mol Biol 313: 10931102.

Thelin M.A, et al. 2013. Biologica function of iduronoic acid in chondroitin/dermatan sulfate.
Journal the FEBS. 280: 2431-2446.

Trowbridge J.M. dan Gallo R.L. 2002. Dermatan sulfate: new functions from an old
glycosaminoglycan. Mini review. Glycobiology. 12 (IX): 117R125R.

Varki A. et al. 2009. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring
Harbor Laboratory Press. ISBN-10: 0-87969-559-5.

Watanabe H et al. 1997. Identification of hyaluronan-binding domains of aggrecan. J Biol

Chem 272: 28057-28065.

Xinhua Lin. 2004. Functions of heparan sulfate proteoglycans in cell signaling during
development. Review. 6009-6021.